Edmond de Rothschild Asset Management (France)’s Biogen BIIB Stock Holding History

Edmond de Rothschild Asset Management (France)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$20.2M	Buy	64,580 +400	+0.6%	+$118K	0.88%	38
2016 Q2	$15.5M	Buy	64,180 +100	+0.2%	+$26.4K	0.69%	43
2016 Q1	$16.7M	Sell	64,080 -6,400	-9%	-$1.69M	0.73%	46
2015 Q4	$21.6M	Buy	70,480 +6,300	+10%	+$1.81M	0.76%	44
2015 Q3	$18.7M	Buy	64,180 +5,000	+8%	+$1.65M	0.62%	57
2015 Q2	$23.9M	Buy	+59,180	New	+$23.8M	0.64%	56

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Edmond de Rothschild Asset Management (France)'s BIIB Position: Q3 2016 in Review

Edmond de Rothschild Asset Management (France) increased its Biogen (BIIB) stake by 0.62% in Q3 2016, buying an estimated $118K and bringing the position to 64,580 shares worth $20.2M. The position accounts for 0.88% of the portfolio, ranked #38.

Edmond de Rothschild Asset Management (France) first reported a position in BIIB in Q2 2015 and has held it in 6 quarters since. The position peaked at $23.9M in Q2 2015. 1,013 funds tracked by Wall St. Rank hold BIIB as of Q3 2016.

Edmond de Rothschild Asset Management (France) held 64,580 shares of Biogen worth $20.2M as of Q3 2016.
Edmond de Rothschild Asset Management (France) bought 400 Biogen shares in Q3 2016, an estimated $118K.
Biogen made up 0.88% of Edmond de Rothschild Asset Management (France)'s portfolio in Q3 2016, its #38 holding.
Edmond de Rothschild Asset Management (France) first reported a position in Biogen in Q2 2015 and has held it in 6 quarters since.
Edmond de Rothschild Asset Management (France)'s Biogen position peaked at $23.9M in Q2 2015.
1,013 funds tracked by Wall St. Rank held Biogen as of Q3 2016.

Based on Edmond de Rothschild Asset Management (France)'s 13F filing for Q3 2016, filed 14 Nov 2016.